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Introduction
Myelination  represents  a  spectacular  cell–cell  interaction  in 
which axons are ensheathed by multiple layers of membrane 
from specialized glia—oligodendrocytes in the central nervous 
system (CNS) and Schwann cells in the peripheral nervous sys-
tem (PNS). The threshold axon diameter for myelination is a 
regulated process, with a minimum axon diameter for myelina-
tion of 1 µm in the PNS and of 0.2 µm in the CNS (Waxman   
and Bennett, 1972; Voyvodic, 1989). Moreover, the number of 
wraps is precisely related to the axon diameter such that the   
ratio of the diameter of the axon to that of the entire myelinated 
unit—the g-ratio—is constant (Friede, 1972). This points to the 
existence of signals on the axon surface that both initiate the 
myelination  process  and  then  determine  exactly  how  many 
times the myelinating process wraps around the axon before the 
extrusion of cytoplasm (a process termed compaction) and the 
formation of the mature multilamellar sheath. In the PNS, a 
necessary and sufficient signal is type III neuregulin-1 (Nrg1), 
increased expression of which on the axon results in a thicker 
myelin sheath, whereas reduced axonal expression results in 
thinner myelin (Michailov et al., 2004; Taveggia et al., 2005). 
The overexpression of Nrg1 also causes the myelination of   
axons whose size is below the normal threshold (Taveggia et al., 
2005), showing that Nrg1 is a signal that initiates myelination in 
addition to its role in regulating wrapping. In the CNS, however, 
the role and identity of any such initiation signals remains un-
known, with the contribution of neuregulins at this and later 
stages of myelination being unclear. Although type III Nrg1
+/ 
mice show reduced myelin sheath thickness in the corpus callo-
sum (Taveggia et al., 2008), normal myelination in mice where 
the Nrg1 gene has been excised in the CNS (Brinkmann et al., 
2008) shows that other signals must contribute to the precise re-
lationship between axon and oligodendrocyte.
Cell adhesion molecules represent excellent candidates for 
these  additional  signals  regulating  myelination  (Laursen  and 
ffrench-Constant, 2007). One of these is 61 integrin, a recep-
tor  expressed  on  oligodendrocytes  for  laminins  expressed  in 
A
ll but the smallest-diameter axons in the central ner-
vous system are myelinated, but the signals that ini-
tiate myelination are unknown. Our prior work has 
shown that integrin signaling forms part of the cell–cell inter-
actions that ensure only those oligodendrocytes contacting 
axons survive. Here, therefore, we have asked whether inte-
grins regulate the interactions that lead to myelination. Using 
homologous recombination to insert a single-copy transgene 
into the hypoxanthine phosphoribosyl transferase (hprt)   
locus, we find that mice expressing a dominant-negative 1 
integrin in myelinating oligodendrocytes require a larger 
axon diameter to initiate timely myelination. Mice with a 
conditional deletion of focal adhesion kinase (a signaling 
molecule activated by integrins) exhibit a similar phenotype. 
Conversely, transgenic mice expressing dominant-negative 
3 integrin in oligodendrocytes display no myelination ab-
normalities. We conclude that 1 integrin plays a key role in 
the axoglial interactions that sense axon size and initiate 
myelination, such that loss of integrin signaling leads to a 
delay in myelination of small-diameter axons.
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precursor migration and proliferation, we generated transgenic 
mice expressing a dominant-negative chimeric 1 integrin (dn1) 
under the control of the 9.5-Kb MBP promoter. This promoter 
drives specific expression in myelinating oligodendrocytes within 
the CNS (Farhadi et al., 2003), as we confirmed in lacZ reporter 
mice that showed expression of -galactosidase only at the time 
of myelination in different white matter tracts (Fig. S1). The 
dominant-negative construct used contains the 1 intracellular 
domain and the extracellular and transmembrane domains were 
replaced by the nonsignaling -subunit of the human interleukin-2 
receptor (IL2R). This chimeric integrin has been shown to 
function in a dominant-negative manner in vitro (LaFlamme   
et al., 1994) and when expressed in oligodendrocyte precursors 
transplanted into demyelinated lesions (Relvas et al., 2001).
To overcome the usual limitations of random and multiple-
copy insertion in standard transgenesis, we used the hypo-
xanthine phosphoribosyl transferase (hprt) targeting system 
(Farhadi et al., 2003) for the generation of the genetically modi-
fied embryonic stem (ES) cells expressing the dn1 integrin 
(Fig. 1 a). This technology uses homologous recombination to 
target a single copy of the desired transgene (in this case the 
dn1 integrin) driven by a specific promoter (in this case the 
MBP promoter) into the hprt locus on the X-chromosome. The 
ES cell line used lacks a complete hprt gene and the targeting 
vector “rescues” the hprt gene by replacing the lost sequences in 
addition to inserting the desired transgene and its promoter. As 
a result, ES cells with the correct insertion can easily be se-
lected by virtue of their expression of hprt and the subsequent 
ability to grow in HAT medium. This process was extremely ef-
ficient, with 12 out of 12 clones selected having the correct in-
sertion, as evidenced by PCR analysis performed as described 
in the Materials and methods (Fig. 1 b). We then generated 
transgenic mice from one of these ES cell lines to establish a 
dn1 transgenic line. These mice had no overt phenotype, and 
in particular showed no evidence of locomotor defects.
A second major advantage of using this technology is that 
single-copy insertion of the transgene into the same place in 
each line eliminates position and copy number effects, and makes 
comparison of multiple transgenic lines unnecessary. This has 
been confirmed by experiments where different mouse lines de-
rived using this strategy from independently targeted ES cell 
clones expressing the same bcl-2 transgene exhibited compara-
ble levels of expression (Bronson et al., 1996) and by our own 
previous studies showing that pairs of transgenic lines express-
ing different MBP regulatory sequences show similar levels of 
-galactosidase  expression  within  each  pair  (Farhadi  et  al., 
2003). Hemizygous and wild-type littermate males of the single 
line were therefore used as mutant and control mice, respec-
tively, throughout this study (Fig. 1 c).
Dn1 mice express the dominant-negative 
1 integrin in white matter tracts
Expression of the dn1 integrin in the mutant was initially con-
firmed by RT-PCR. Primers hybridizing to the human IL2R gene, 
only present in the inserted dominant-negative construct, showed 
specific amplification in mutant mice (Fig. 2 a). To visualize the 
expression of the dn1 integrin protein in the myelinating tracts, 
axon tracts at the time of myelination that promotes oligoden-
drocyte survival by amplification of growth factor signaling 
(Colognato et al., 2002). This provides a mechanism for the   
target-dependent survival of oligodendrocytes, with those that fail 
to establish normal contact with axons during development under-
going programmed cell death. The importance of integrins in   
oligodendrocyte biology is further underscored by the finding 
that integrin-mediated signaling pathways are strongly repre-
sented in a genome-wide analysis of expression in differentiating 
oligodendrocytes (Cahoy et al., 2008). Here, therefore, we have 
asked whether integrins play a role in the regulation of myelina-
tion, either by contributing to the signals that initiate myelination 
or by regulating the thickness of the resulting myelin sheath.
Prior studies on the role of 1 integrin in CNS myelination 
in vivo have been contradictory. Constitutive disruption of the 1 
integrin gene resulted in early lethality (Fassler and Meyer, 1995; 
Stephens et al., 1995), requiring the use of conditional ablation or 
dominant-negative strategies to examine function. Lee et al. (2006) 
reported that mice expressing a 1 integrin lacking the C-terminal 
cytoplasmic tail (1C) in oligodendrocytes displayed region-
specific hypomyelination in optic nerve and spinal cord and no 
myelination abnormalities in the corpus callosum. In contrast, 
conditional inactivation of the 1 integrin gene in premyelinating 
oligodendrocytes showed that 1 integrin is not required for CNS 
axon ensheathment, myelination, or remyelination (Benninger 
et al., 2006). Nonetheless, the contribution made by integrin sig-
naling to oligodendrocyte survival, evidenced by our earlier studies 
on the 6 knockout CNS, was confirmed by a transient reduc-
tion in oligodendrocyte numbers in the developing cerebellum 
(Benninger et al., 2006). However, it is possible that both these 
studies fail to reveal the specific function of 1 integrin in myelin-
ating oligodendrocytes. In the knockout study, gene deletion 
occurs early, at the premyelinating stage of oligodendrocyte devel-
opment, thus potentially enabling compensation by other integrins 
to occur by the stage of myelination. The ability of different integ-
rin  subunits to compensate for one another has been previously 
shown  in  Drosophila  embryogenesis  (Martin-Bermudo  et  al., 
1999). In the dominant-negative study, the construct used by Lee 
et al. (2006) contained a normal integrin extracellular domain that 
will bind laminin and compete with any other laminin receptors 
for available ligand in the myelinating tract. Here, therefore, we 
have used the reverse strategy—expression in oligodendrocytes of 
a well-characterized dominant-negative 1 integrin subunit con-
taining only the intracellular domain that will not bind ligand and 
would thus be predicted to be more specific in targeting 1 integ-
rin signaling (LaFlamme et al., 1994; Relvas et al., 2001). Further-
more, we have minimized the time available for compensatory 
mechanisms to develop by expressing the dominant-negative sub-
unit only at the myelinating stage in oligodendrocytes using the 
myelin basic protein (MBP) promoter (Farhadi et al., 2003).
Results
Generation of dominant-negative 1 
integrin transgenic mice (dn1)
To examine the role of 1 integrin signaling in myelination in 
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this RT-PCR analysis on several areas of the nervous system. 
We showed that in all CNS white matter tracts the dn1 inte-
grin expression levels were equal to or greater than the levels of 
the mRNA for the endogenous integrin, with significantly 
higher levels seen in optic nerve (Fig. 3 b). The same expres-
sion pattern was observed in four pairs of mice analyzed, with 
the mean levels of the dn1 mRNA relative to the wild-type   
1 mRNA being 2.22 ± 0.37 in optic nerve (P = 0.033), 1.6 ± 0.37 
in spinal cord, and 1.22 ± 0.17 in cerebellum, as compared with 
0.92 ± 0.10 in cortex.
Second, to show directly that the dominant-negative strat-
egy we used inhibits downstream signaling, as predicted from 
these expression studies, we examined activation of FAK by   
tyrosine phosphorylation. Activation of FAK via autophosphory-
lation, on tyrosine 397, occurs after integrin binding to ECM   
ligands (Schaller et al., 1994). We showed, by Western blot 
analysis for P-FAK (Y397), that 1 integrin signaling was sig-
nificantly reduced (45 ± 9.3%, P = 0.018, n = 3 pairs of animals) 
in the optic nerve of P18 dn1 mice, as compared with wild-
type mice of the same age (Fig. 3 c). Similar changes were seen 
in spinal cord, but these did not reach statistical significance.
The relationship between axon diameter 
and myelin thickness is normal in dn1 mice
To examine myelination in the dn1 mice, we first compared 
white matter tracts in several CNS regions of wild-type and dn1 
mice by immunohistochemistry using an anti-MBP antibody. We 
observed no differences in these studies, with the white matter 
tracts visualized in sections of corpus callosum and optic nerve 
showing identical thickness and labeling intensity (Fig. S2).
To assess myelination in more detail, we performed an   
ultrastructural electron microscopy (EM) analysis on optic nerve, 
spinal cord, and cerebellum at P28, an age when myelination is 
largely complete (Fig. 4). We found that the relationship be-
tween axon diameter and myelin thickness (g-ratio) was not sig-
nificantly different between dn1 mutants and their wild-type 
we used immunofluorescence labeling with an anti–human 
IL2R antibody on transverse sections of optic nerve, sagittal 
sections of cerebellum, and coronal sections of corpus callosum 
in wild-type and mutant mice (Fig. 2 b). The dn1 integrin was 
expressed in white matter tracts within these regions in mutant 
mice, whereas no expression was detected in the wild-type ani-
mals. These results confirm that the dn1 integrin is expressed 
in transgenic mice at the RNA and protein level in the predicted 
pattern within myelinating tracts.
Next, we tested if this expression was specific to the ner-
vous system. We analyzed RNA from several tissues of the 
dn1 mice by RT-PCR (Fig. 2 c). Transgene expression was 
found to be restricted to cortex, cerebellum, brainstem, spinal 
cord, optic nerve, and sciatic nerve and absent from other tis-
sues such as heart, liver, lungs, kidney, muscle, testis, spleen, 
and stomach. This confirms that, as we would predict from the 
known expression pattern of the MBP, the dn1 expression is 
restricted to the nervous system.
Integrin signaling is inhibited in the  
dn1 mice
To confirm the efficacy of our strategy, we asked to what extent 
the dn1 construct expressed in the transgenic mice inhibited 
the endogenous 1 integrin. First, we compared the expression 
levels of the endogenous and the transgenic 1 integrin. In vitro 
studies have demonstrated that approximately equal expression 
levels of the IL2R-integrin chimera to the endogenous integrin 
are sufficient to inhibit integrin-mediated cell spreading and 
migration, confirming that this level of transgene expression   
exerts a dominant-negative effect (LaFlamme et al., 1994).   
We therefore designed a semi-quantitative RT-PCR analysis 
using two distinct sets of primers, one specific for the endoge-
nous 1 integrin and another for the dn1 integrin, taking ad-
vantage of the differences in their extracellular domains (Fig. 3 a). 
To examine whether the levels of 1 integrin inhibition might 
vary in the different areas of the nervous system, we performed 
Figure  1.  Generation  of  dominant-negative 
1 integrin transgenic mice (dn1). (a) The hprt 
targeting system used in our study: the dn1 
transgene (comprising the IL2R extracellular 
and transmembrane domains and the 1 integ-
rin cytoplasmic domain) and the MBP promoter 
were  inserted  by  homologous  recombination 
in single copy into the disrupted hprt locus on 
the X-chromosome of the hprt () ES cell line. 
The targeting vector contains the missing hprt 
sequences and thus restores hprt functionality 
and enables subsequent growth of the ES cells 
in HAT medium. (b) Transfected hprt () ES cells 
bearing a functional hprt gene (after successful 
recombination) were selected for HAT medium 
and screened by PCR using the primers repre-
sented as arrows in panel a. A band of 290 bp 
indicates the presence of the dn1 transgene. 
Twelve out of the twelve HAT
+ clones correctly 
recombined. (c) Genotyping of transgenic mice 
was performed by PCR for wild-type (Wt) and 
dn1 transgenic alleles (dn1). Genotype of 
the four animals shown: Wt, wild-type; Hem, 
hemizygous male; Het, heterozygous. Panel a 
was adapted from Bronson et al. (1996).JCB • VOLUME 185 • NUMBER 4 • 2009   702
The axon diameter required to initiate 
myelination is increased in the dn1 mice
We reasoned that an analysis of development might reveal tran-
sient abnormalities of myelination not seen in the fully developed 
myelinated tracts. We therefore examined optic nerve at P17, a 
time at which myelination is not yet complete. As in the later 
stages, no significant differences in the thickness of those myelin 
sheaths that had formed and appeared fully compacted by this age 
were detected in the optic nerve (P = 0.65), with average g-ratios 
for control and mutant mice of 0.79 ± 0.007 and 0.80 ± 0.016, re-
spectively (Fig. 5, a and b). Interestingly, however, we noted at 
counterparts in P28 optic nerve, cerebellum, and spinal cord, 
with average g-ratios for control and mutant optic nerves of 
0.79 ± 0.013 and 0.77 ± 0.020 (P = 0.57); for control and mutant 
cerebella of 0.80 ± 0.014 and 0.82 ± 0.019 (P = 0.43); for con-
trol and mutant spinal cords of 0.80 ± 0.001 and 0.79 ± 0.004   
(P = 0.36), respectively. Additionally, no evidence of a higher fre-
quency of dysmyelinated axons in mutant optic nerve, corpus 
callosum, or spinal cord was observed. We conclude that, for 
myelinated axons, the myelin morphology and the ratio of my-
elin thickness/axon diameter in the dn1 mutants are the same 
as in wild-type mice at P28.
Figure 2.  Dn1 mice express the dominant-negative 1 integrin in white matter tracts. (a) RT-PCR analysis from cortex of 3-mo-old wild-type (Wt) and 
transgenic mice (dn1) reveals RNA expression of 1 integrin in both Wt and transgenic mice but dn1 integrin (IL2R) only in the mutant. (b) Anti–human 
IL2R immunolabeling of optic nerve transverse sections (bar: 33 µm), cerebellar sagittal sections (bar: 33 µm), and corpus callosum coronal sections (bar: 
66 µm) from P18 wild-type and dn1 mice shows that the dominant-negative integrin protein is expressed in the myelinating tracts of mutant mice. (c) Dn1 
expression is nervous system specific as confirmed by an RT-PCR analysis on various tissues from P22 mutant mice. IL2R primers were used for detection 
of the dn1 expression (top). Actin primers were used as control (bottom).703 1 INTEGRIN AND CNS MYELINATION • Câmara et al.
showing that the effect of loss of integrin signaling is only on 
the initiation of myelination and results in a delay, rather than in 
a long-lasting perturbation, in the formation of normal myelin 
sheaths. This correction resulted from restoration of the ability 
of the mutant oligodendrocytes to myelinate smaller-diameter 
axons with age, rather than an overall increase in axon diameter, 
as evidenced by the higher percentage of axons with a diameter 
less than 0.5 µm that are myelinated at P28. Thus, at P17 the 
percentage of axons myelinated of diameters 0.2–0.3, 0.3–0.4 
and 0.4–0.5 µm were 1.2, 12.7, and 37.2%, whereas at P28 the 
percentages were 6.1, 51.4, and 83.6%, respectively.
As  an  alternative  method  to  demonstrate  the  increased 
threshold diameter required to initiate myelination in the dn1 
mice, we compared the frequency distribution of the diameters 
of all myelinated and total axons (irrespective of myelination 
status) between wild-type and dn1 mutants in P17 optic nerve 
(Fig. 5 e). As predicted from the observations above, both the 
mean myelinated and unmyelinated axon diameters were signif-
icantly larger (P < 0.0001) in mutant optic nerves (0.86 ± 0.015 µm 
for  myelinated  axons,  0.38  ±  0.004  µm  for  unmyelinated   
axons) than in their wild-type littermate controls (0.75 ± 0.012 µm 
and 0.35 ± 0.004 µm, respectively). By contrast, the mean diam-
eter of all axons was not significantly different, with an average 
axon diameter of 0.47 ± 0.006 µm and 0.48 ± 0.007 µm for wild-
type and mutant, respectively (P = 0.21). This excludes the pos-
sibility that changes in the distribution of axon diameters might 
contribute to the effects on myelination we observe.
A greater threshold for myelination is also 
seen in FAK-deficient mice
If the increased threshold for myelination we observed in the 
dn1 mice reflects an inhibition of integrin signaling, then we 
this age that wild-type oligodendrocytes were myelinating smaller 
axons to a larger extent than their dn1 counterparts. This became 
apparent in the g-ratio analysis by a reduced population of myelin-
ated axons with small diameters in dn1 optic nerves as compared 
with wild-type nerves (Fig. 5 c). These very small axons must 
therefore have been unmyelinated in the dn1 nerve. We therefore 
hypothesized that oligodendrocytes with inhibited 1 integrin sig-
naling would require a higher axon diameter to initiate myelina-
tion. To address this question, we compared the relationship 
between axon diameter and the percentage of axons myelinated 
for wild-type and dn1 mice. We measured the axon diameter of 
more than 400 axons from at least three random nonoverlapping 
photos and scored them as myelinated or unmyelinated. The axon 
diameters were then subdivided into 0.1-µm intervals and plotted 
against the percentage of axons that were myelinated within each 
interval (Fig. 5 d). As some variability was noted between litters, 
littermate controls were examined in each case. The percentage of 
myelinated axons across all axon diameter intervals for the dn1 
mutant optic nerves (62.08 ± 10.55%, n = 2,494 from 3 animals) 
was lower (P = 0.023) than for their wild-type littermates (66.30 ± 
10.09%, n = 2,506 from 3 animals). This phenotype was most evi-
dent in small axons of ≤0.6 µm diameter (P = 0.0085), whereas   
a similar percentage of myelination was seen in larger axons of 
>0.6 µm of diameter. In particular, mutant axons of a diameter 
within the 0.3–0.4-µm range showed the most significant reduction 
in myelination as compared with wild-type controls (P = 0.023). 
These results therefore show that the threshold diameter required to 
initiate myelination is increased in the dn1 optic nerve.
To confirm that this effect was transient and only seen 
during myelinating stages of development, we next repeated the 
analysis on the older P28 optic nerves. Here no difference was 
seen between wild-type and dn1 littermate animals (Fig. S3), 
Figure 3.  Integrin signaling is inhibited in the dn1 
mice. (a) Design of a semi-quantitative RT-PCR using 
two distinct sets of primers (represented as arrows) 
binding the extracellular domains of the endogenous 
(1) and the transgenic (IL2R) 1 integrins to evaluate 
their relative expression levels. (b) The dn1 integrin 
(IL2R)  is  expressed  at  equal  or  greater  levels  than 
those for the endogenous 1 integrin (1) in all areas 
of the CNS, with the highest levels present in spinal 
cord and optic nerve. A single experiment is shown; 
quantification of four sets of experiments is presented 
in the text. (c) Western blot analysis for P-FAK (Y397) 
shows that integrin downstream signaling is reduced 
in spinal cord and optic nerve in mutant mice (dn1) 
as compared with the levels seen in wild-type mice 
(Wt). Antibodies against FAK and actin were used as 
controls. A single experiment is shown, with quantita-
tive results from three sets of experiments presented 
in the text.JCB • VOLUME 185 • NUMBER 4 • 2009   704
initiate myelination. As a result, the smallest axons no longer 
generate a signal within the oligodendrocyte of sufficient strength 
to trigger myelination. Second, a reduction in oligodendrocyte 
numbers such that there are no longer sufficient cells to myelin-
ate all available axons. In this last situation, it would be expected 
that those axons myelinated last during development, i.e., the 
smallest-diameter axons (Remahl and Hildebrand, 1982), would 
be myelinated late or not at all during development in the mutant 
mouse. The former mechanism represents an intrinsic defect in 
the oligodendrocyte, whereas the latter is an extrinsic effect sec-
ondary to a reduction in cell numbers.
To discern which mechanism is responsible for our ob-
servations, we performed co-culture experiments in which 
oligodendrocytes are provided in considerable excess (thus 
eliminating any extrinsic effects of cell number variation) and 
examined myelination by oligodendrocytes derived from wild-
type or dn1 mice. These oligodendrocytes were cultured in the 
presence of wild-type dorsal root ganglion (DRG) neurons and 
their myelination efficiency was evaluated as described else-
where (Wang et al., 2007) by determining the percentage of oligo-
dendrocytes forming myelin. Although not the normal target   
of CNS oligodendrocytes, axons formed by DRG neurones 
grown in culture have a range of diameters of less than 2 µm 
(Fig. S4 a), similar to those in the optic nerve studied here, and are 
myelinated by oligodendrocytes added to these cultures. They 
therefore provide an appropriate test of the intrinsic myelino-
genic capacity of the oligodendrocyte. We found that dn1 oligo-
dendrocytes myelinated DRG axons significantly less efficiently   
would predict that other transgenic mice having perturbations 
of downstream signaling molecules should show a similar pheno-
type. To test this we examined P16–P21 optic nerves from mice 
in which FAK had been deleted in myelinating glial cells by 
crossing mice homozygous for a floxed FAK allele with a Cnp-
Cre line (Grove et al., 2007). As discussed above, FAK is a key 
part of the integrin signaling pathway, binding to the integrin 
cytoplasmic domain and being activated by phosphorylation   
after integrin ligand binding, and loss of FAK activity in oligo-
dendrocytes has very recently been shown to result in hypo-
myelination in the developing mouse optic nerve (Forrest et al., 
2009). Similarly to the dn1 mice, we found that an increased 
threshold diameter was required for myelination at this age, as 
evidenced  by  a  reduced  percentage  of  myelinated  axons  in 
knockout (57.37 ± 10.38%, n = 2,186 from 4 animals) com-
pared with wild-type (64.93 ± 10.70%, n = 2,560 from 4 ani-
mals) optic nerves of P16–P21 animals (P = 0.0087; Fig. 6), 
whereas there was no difference in the percentage of myelinated 
axons in adult (P60) nerves (Fig. S3).
Dn1 oligodendrocytes myelinate a  
reduced number of internodes in 
myelinating co-cultures
There are two general mechanisms by which the increase in 
axon diameter required for myelination in the P17 optic nerve 
might be explained. First, an intrinsic abnormality of the oligo-
dendrocyte such that it cannot respond appropriately to the   
axoglial signal proportional to axon diameter that is required to 
Figure 4.  The relationship between axon diameter and myelin thickness is normal in dn1 mice. (a) Representative electron micrographs of sections of 
optic nerve, spinal cord, and cerebellum of P28 wild-type and dn1 mutant mice. Bar: 1 µm. (b) The linear regression of the g-ratio measurements for each 
animal (n = 3) is shown for the three CNS areas. Solid and dashed lines represent wild-type and mutant animals, respectively. (c) Scatter plot displays   
g-ratios of individual myelinated axons (obtained from three animals) as a function of the respective axon size. Closed and open circles represent wild-type 
and mutant axons, respectively.705 1 INTEGRIN AND CNS MYELINATION • Câmara et al.
wild-type: 45.8 ± 0.9 µm; dn1: 44.2 ± 0.8 µm, n = 5) or in the 
number of primary processes generated by each oligodendro-
cyte (wild-type: 4.12 ± 0.10, n = 74 from 4 experiments; dn1: 
4.25 ± 0.12, n = 79 from 4 experiments). We conclude, there-
fore, that the increased axon diameter required for myelination 
reflects an intrinsic abnormality of axoglial signaling within the 
dn1 oligodendrocytes.
Dn3 mice show no evidence of altered 
axon diameter threshold for myelination
A concern with the use of the dominant-negative expression 
strategy is that the phenotype might reflect nonspecific effects 
of transgene expression on the cell surface. To control for this, we 
generated a second line of mice expressing a dominant-negative 
(P < 0.01) than wild-type oligodendrocytes (Fig. 7). To show 
any intrinsic defect more clearly, we then asked whether each 
dn1 oligodendrocyte myelinated a reduced number of inter-
nodes and/or internodes with reduced length. We therefore 
quantified for each individual cell the number and average length 
of internodes in a total of 50 wild-type and dn1 oligodendro-
cytes in co-culture. Dn1 oligodendrocytes showed a reduced 
number of internodes (37 ± 2) when compared with wild-type 
(50 ± 5) oligodendrocytes (P < 0.05, n = 5). This difference was 
not due either to a reduced neurite density or perturbed oligo-
dendrocyte differentiation in the dn1 cultures, as these were 
similar in the cultures of all three genotypes (Fig. S4 b). By 
contrast, no difference was found between the average internodal 
length per oligodendrocyte from the two genotypes (Fig. S4 c, 
Figure 5.  The axon diameter required to initiate myelination is increased in the dn1 mice. (a) Representative electron micrographs show a reduction in 
the frequency of small myelinated axons in optic nerve sections of P17 dn1 mutant mice compared with wild-type mice. Bar: 1 µm. (b) Normal myelin 
morphology and thickness in P17 optic nerve of dn1 mice. The linear regression of the g-ratio measurements for each animal (n = 3) is shown. Solid and 
dashed lines represent wild-type and mutant animals, respectively, from three litters displayed in blue, green, and red. (c) A reduced number of myelinated 
small-diameter axons is observed in dn1 mutants (open figures) compared with wild-type animals (closed figures). This is especially clear in two of the three 
litters analyzed, identified by different colors as in b. The scatter plots shown display g-ratios of individual myelinated axons as a function of the respective 
axon size, with the two parts of the plot corresponding to small and large axons shown separately (in left and right panels, respectively) and the former 
expanded to show the differences more clearly. Closed and open figures represent wild-type and mutant axons, respectively. (d) Representative graph from 
one litter shows the percentage of myelinated axons with respect to axon diameter at 0.1 µm intervals for wild-type and dn1 mice. A polynomial trendline 
was adjusted to the data. A reduced percentage of myelination across all axon diameter intervals is present in dn1 mutant compared with wild-type mice 
(*, P < 0.05), a phenotype most evident in small axons below 0.6 µm of diameter (**, P < 0.01). (e) Frequency histogram of the diameter of all the myelin-
ated and total (both myelinated and unmyelinated) axons shows a shift of myelinated axons toward larger diameters in mutant animals, whereas the total 
distribution of axon diameters remains unchanged.JCB • VOLUME 185 • NUMBER 4 • 2009   706
curve created by plotting axon diameter versus the percentage 
myelinated as schematized in Fig. 9. A similar phenotype was 
seen when the downstream signaling molecule FAK was de-
leted in myelinating glial cells. In mice expressing the dominant-
negative 1 integrin transgene, we also observed that the thickness 
of the myelin sheath in those axons that do become myelinated 
is normal, as is the length of the myelin internodes as measured 
in myelinating co-cultures. We conclude, therefore, that inhibi-
tion of integrin signaling delays the initiation of myelination but 
has no effect on the signals required for the formation of the 
sheath once the axoglial interactions that lead to myelination 
have been established. It follows, therefore, that integrins con-
tribute to the axoglial interactions that initiate myelination.
Given the evidence from myelinating co-culture experi-
ments revealing an intrinsic defect in oligodendrocyte myelina-
tion, two broad mechanisms can be put forward to explain our 
observations—perturbation of the axoglial signaling that initi-
ates myelination or a failure of oligodendrocyte differentiation 
(Fig. 10). The first would be based on the observation that in the 
PNS an axonal signal proportional to the diameter and above a 
certain threshold is required to initiate myelination by the con-
tacting glial cell (Taveggia et al., 2005; Nave and Salzer, 2006). 
If there is a reduction in the glial response to the axonal signal 
due to perturbation of integrins, then the prediction would be 
that the signal on the small axons will not be detected as above 
the required level and a reduced percentage of myelination of 
these small-diameter axons will be observed. In contrast, the 
large axons could either provide a signal that is in excess of the 
threshold level or express an additional signaling molecule that 
initiates myelination without any requirement for integrin func-
tion, and thus would not be affected by integrin perturbation.   
In the second mechanism, small-diameter axons could be prefer-
entially affected by the reduction in 1 integrin signaling as a 
result of a compromised ability of the oligodendrocyte to change 
their morphology and generate multiple processes for myelina-
tion. It has been shown that toad oligodendrocytes myelinating 
small axons extend more processes than those myelinating large 
axons (Stensaas and Stensaas, 1968; Hildebrand et al., 1993). 
subunit for 3 integrin (Fig. S5). 3 integrin is expressed on oligo-
dendrocyte precursors but is not present at the myelinating 
stages (Milner et al., 1997). The construct used is identical to 
that for the dn1 mice except for the substitution of a 3 cyto-
plasmic domain for the 1 sequences. The same hprt targeting 
method was used to generate the dn3 transgenic mice, thus 
creating single-copy insertion into exactly the same locus as 
with the dn1 mice. This ensures comparable expression of the 
two coding sequences, as confirmed by immunofluorescence 
analysis showing the distribution and expression pattern of the 
dn3 protein to be the same as that previously seen for dn1 
protein (Fig. S5). Hemizygous and wild-type male littermate 
mice were generated and compared with the dn1 mice. Dn3 
mice revealed no defect in CNS myelination at P17 with no sig-
nificant differences seen in the percentage of axons myelinated 
across all axonal intervals (dn3: 58.73 ± 10.54, n = 1,397 from 
3 animals; wild type: 54.07 ± 10.41, n = 1,416 from 3 animals; 
P = 0.24) and no evidence for a lack of myelination in the 
smaller-diameter  axons  as  seen  for  the  dn1  mice  (Fig.  8). 
Equally, no effect of the expression of dn3 on the myelination 
efficiency, the number of internodes, and the number of pro-
cesses formed by each individual oligodendrocyte was detected 
in  the  myelinating  co-culture  assay.  Dn3  oligodendrocytes 
generated 47 ± 1 internodes of average length 43.6 ± 0.6 µm and 
4.44 ± 0.10 primary processes (n = 98 from 4 experiments), 
numbers not significantly different from wild-type cells (Fig. 7). 
We conclude that the phenotype we observed in the dn1 mice 
is not a nonspecific effect of transgene expression, but rather a 
specific effect of perturbing 1 integrin signaling.
Discussion
We show that oligodendrocytes expressing a single copy of a 
dominant-negative 1 integrin transgene myelinate small-diameter 
axons in optic nerve less efficiently than wild-type or control 
(dominant-negative 3) oligodendrocytes. This presents as a tran-
sient failure to myelinate small-diameter axons during develop-
ment, demonstrated by a shift to the right of the dose–response 
Figure 6.  A greater threshold for myelination is also seen in FAK-deficient mice. (Left) Representative electron micrographs show a reduction in the fre-
quency of small myelinated axons in optic nerve sections of P16-P21 FAK knockout mice compared with wild-type mice. Bar: 1 µm. (Right) Representative 
graph from one litter shows the percentage of myelinated axons with respect to axon diameter at 0.1-µm intervals for wild-type and dn1 mice. A poly-
nomial trendline was adjusted to the data. A reduced percentage of myelination across all axon diameter intervals is present in FAK knockout compared 
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reorganization would therefore be expected to reveal a pheno-
type in those tracts where more processes are required, i.e., 
those with small-diameter axons. In agreement with this, knockout 
mice for the regulator of the actin cytoskeleton WAVE1 exhib-
ited a reduced number of myelinated axons in the optic nerve 
Additionally, oligodendrocytes in rat white matter areas consti-
tuted of small axons possess more branches than those in areas 
with both large and small axons (Matthews and Duncan, 1971). 
A reduction in 1 integrin signaling that compromises process 
outgrowth via the established role of this receptor in cytoskeletal 
Figure 7.  Dn1 oligodendrocytes myelinate a reduced number of internodes in myelinating co-cultures. (a) Representative pictures are shown for wild-
type, dn1, and dn3 MBP
+ oligodendrocytes myelinating neurites within DRG neuron cultures at low (top panels) and high (bottom panels) magnification. 
Bars: top, 133 µm; bottom, 50 µm. (b) (left) Neurosphere-derived dn1 oligodendrocytes myelinate DRG neurons less efficiently than their wild-type or 
dn3 counterparts. Error bars represent SD (**, P < 0.01). The internodal number (middle) and length (right) were quantified for each oligodendrocyte (10 
oligodendrocytes per experiment, n = 5). Dn1 oligodendrocytes showed a decrease in the internodal number per oligodendrocyte (*, P < 0.05), whereas 
the internodal length was unchanged for the three genotypes.
Figure 8.  Dn3 mice show no evidence of altered axon diameter threshold for myelination. (Left) Representative electron micrographs of optic nerve sections 
of P17 wild-type and dn3 transgenic mice show no differences. Bar: 1 µm. (Right) Representative graph from one litter shows the percentage of myelinated 
axons with respect to axon diameter at 0.1-µm intervals for wild-type and dn3 mice. A polynomial trendline was adjusted to the data. The axon diameter 
threshold for myelination is unaffected in dn3 transgenic mice.JCB • VOLUME 185 • NUMBER 4 • 2009   708
a result that rather compellingly argues against a necessary role 
for Nrg1 signaling in CNS myelination. Additional neuregulin 
isoforms may be important in the CNS but equally, and in contrast 
to the PNS, other axonal signals may be required for regulating 
myelination. These may also be amplified by integrins, as seen for 
a number of different growth factors in other cell types. The hy-
pothesis that such multi-component signaling complexes initiate 
and regulate myelination by oligodendrocytes provides a mecha-
nism to explain the “catch-up” by the mutant oligodendrocytes in 
the older animals, as compensatory interactions within the com-
plex will facilitate restoration of normal axoglial interactions.
Interestingly, both in monkeys and humans the area of the 
CNS  most  prone  to  remyelination  failure  is  the  optic  nerve 
(Lachapelle et al., 2005). A model in which amplification of a 
myelination signal is required for small- but not large-diameter 
axon myelination could explain both the vulnerability of the   
optic nerve and the regional selectivity of the phenotype seen in 
the dn1 mouse, as the optic nerve contains entirely small- 
diameter axons. Similar regional differences in myelination are 
observed in other mutants that perturb integrin signaling, such 
as the Fyn knockout and the laminin-2–deficient (dy/dy) mouse. 
In these mice myelination defects are seen in optic nerve but not 
in spinal cord, where the density of larger axons is higher. 
Another possibility to explain regional heterogeneity, intrinsic 
differences in the oligodendrocytes arising from different re-
gions of the developing CNS, seems less likely given that abla-
tion of one such population is followed by replacement from a 
different region (Kessaris et al., 2006). In addition, transplanta-
tion of oligodendrocytes from optic nerve into spinal cord re-
veals that the transplanted cells can myelinate the full range of 
axon diameters in their new environment, even though these di-
ameters are much greater than those present in their original lo-
cation (Fanarraga et al., 1998).
Although the two previous studies examining the role of 
1 integrins in regulating CNS myelination appear contradictory 
(Benninger et al., 2006; Lee et al., 2006), the current study allows 
their reconciliation. Here we have concluded that inhibition of 
integrins perturbs axoglial signaling and delays myelination of 
and corpus callosum, with WAVE1 knockout oligodendrocytes 
showing a reduced number of processes in cell culture (Kim 
et al., 2006).
Three observations argue against the latter mechanism—
perturbation of cytoskeletal function as the cause of the pheno-
type in the dn1 mice. First, although the number of internodes 
myelinated by each dn1 oligodendrocyte in the myelinating 
cocultures is reduced, the length of internodes is unaltered, with 
the majority of internodes myelinated by wild-type, dn1, and 
dn3 oligodendrocytes distributed between 27 and 40 µm as 
recently reported for cortical oligodendrocytes in vivo (Murtie 
et al., 2007; Fig. S4 c). A compromised ability of the oligoden-
drocyte to extend processes would be expected both to reduce 
the number of internodes and to shorten internodal length, as 
this latter measurement must reflect process extension along the 
axon once contact has been established. Second, the similar   
g-ratios seen in the P17 optic nerve of wild-type and dn1 mice 
show that the cytoskeletal reorganization required for myelin 
sheath compaction is not affected by inhibition of integrin sig-
naling. Third, the number of primary processes is not significantly 
different between wild-type, dn1, and dn3 oligodendrocytes 
in premyelinating co-cultures. Dn1 oligodendrocytes are, there-
fore, able to extend processes normally, as evidenced by their 
number of primary processes and internodal length, but then 
myelinate less efficiently with fewer internodes.
The conclusion that oligodendrocyte integrins form part 
of the recognition complex for axonal signals that determine 
whether or not myelination occurs is important, as the identity 
of such axonal signals in the CNS is unknown. In the PNS, the 
level of axonal type III Nrg1 has been shown to play a crucial 
role in determining both whether an axon is myelinated and in 
the  regulation  of  myelin  thickness  (Michailov  et  al.,  2004; 
Taveggia et al., 2005). We have shown that laminin-binding in-
tegrins amplify neuregulin signaling as part of the mechanisms 
that regulate target-dependent survival of newly formed oligo-
dendrocytes in the CNS (Colognato et al., 2002). Our results 
here would therefore be consistent with a model in which axo-
nal  neuregulins  in  the  CNS,  recognized  by  oligodendrocyte 
ErbB receptors, generate a signal to initiate myelination that is 
further amplified by integrins. In the case of small-diameter   
axons, this amplification is essential for triggering myelination, 
whereas large-diameter axons generate sufficient signal without 
integrin amplification. However, the role of neuregulins in CNS 
myelination has not been resolved. Exogenous addition of Nrg1 
promotes myelination in co-cultures of oligodendrocytes and 
DRG neurons (Wang et al., 2007) and myelination of type III 
Nrg1-deficient DRG neurons is significantly reduced in co- 
culture (Taveggia et al., 2008). Hypomyelination is seen in trans-
genic mice expressing a dominant-negative ErbB receptor in 
oligodendrocytes,  and  in  mice  haploinsufficient  for  type  III 
Nrg1 (Roy et al., 2007; Taveggia et al., 2008). However, in con-
trast to the PNS, increased expression of this axonal signal does 
not promote myelination of very small, and normally unmyelin-
ated, axons in co-cultures of superior cervical ganglion neurons 
and oligodendrocytes (Taveggia et al., 2008). Moreover, condi-
tional mutants with ablation of Nrg1, ErbB3, or ErbB4 exhibit 
no cortical myelination abnormalities (Brinkmann et al., 2008), 
Figure 9.  The expression of dn1 integrin shifts the axon diameter thresh-
old for myelination toward larger diameters, shown here schematically by 
a shift to the right of the dose–response curve created by plotting the per-
centage of axons myelinated against the axon diameter. By contrast, the 
increased expression of Nrg1 in the PNS was previously shown to shift the 
myelination threshold toward lower axon sizes, i.e., to the left.709 1 INTEGRIN AND CNS MYELINATION • Câmara et al.
extracellular domain will form heterodimers with integrin-  
subunits and thus compete for ligand with other oligoden-
droglial laminin receptors. One of these is dystroglycan (Colognato 
et al., 2007), for which the main binding site on laminin over-
laps with that of integrins at the laminin G domains LG1-3 (Talts 
et al., 1999; Wizemann et al., 2003). We have shown that dystro-
glycan is a significant laminin receptor for CNS myelination 
in vitro, and transgenic studies reveal an essential role in PNS 
small-diameter axons, but has no effect on the subsequent forma-
tion of the myelin sheath. This conclusion is consistent with our 
previous report on the absence of g-ratio disturbances in the   
oligodendrocyte-specific conditional 1 knockout (Benninger   
et al., 2006), where the analysis focused on myelin sheath thickness 
in older animals. Hypomyelination after expression of 1C (Lee   
et al., 2006) can be explained by a requirement for dystroglycan in 
sheath formation. As noted in the introduction, the 1C integrin 
Figure 10.  Models for the failure in myelination of small-diameter axons resulting from perturbed 1 integrin signaling. (a) The oligodendrocyte initially 
extends processes to reach large and small axons and then initiates myelination. Large axons are myelinated earlier than small axons. (b) Model I: an   
axonal signal proportional to the diameter and above a certain threshold is required to initiate myelination by the contacting glial cell. Due to the expression 
of dn1 integrin there is a reduction in the glial signaling in response to this signal, such that the signal initiated by some small axons will now not be above   
the required (threshold) level for myelination. By contrast, the large axons provide a signal that is significantly in excess of the threshold level and/or   
additional signals, and thus will not be affected by perturbation of integrin signaling. (c) Model II: myelinating tracts rich in small-diameter axons require more 
oligodendrocyte processes than those tracts rich in large axons. Small axons are, therefore, particularly susceptible to any failure of the oligodendrocyte to 
generate multiple processes for myelination, as might occur after perturbation of integrin signaling, leading to an impaired ability of the cell to reorganize 
the cytoskeleton. See text for a discussion of the evidence for and against the two models.JCB • VOLUME 185 • NUMBER 4 • 2009   710
Charlesworth et al., 2006) with transgenic mice expressing cre recombi-
nase under the regulation of the CNP promoter (a gift of Dr Klaus Nave, 
Gottingen, Germany) has been described elsewhere (Grove et al., 2007).
Myelinating co-cultures
Dorsal root ganglia (DRGs) were dissected from E14–E16 rats and di-
gested for 45 min at 37°C with 1.2 U/ml papain (Worthington), 0.24 
mg/ml l-cysteine (Sigma-Aldrich), and 40 µg/ml Dnase I (Sigma-Aldrich). 
The dissociated cells were plated onto 22-mm coverslips precoated with 
poly-d-lysine (10 µg/ml; Sigma-Aldrich) followed by matrigel (1:20 dilu-
tion; BD Biosciences) at a density of 5 × 10
5 cells/ml. The DRGs were 
grown for two weeks in DMEM supplemented with 10% fetal bovine   
serum (Invitrogen) and nerve growth factor (NGF, 100 g/ml; AbD Sero-
tec).  The  cultures  were  pulsed  three  times,  for  2  d  each  time,  with 
fluorodeoxyuridine (10 µM; Sigma-Aldrich) to remove contaminating   
fibroblasts and glial cells. Neurospheres from wild-type or mutant litters 
were added to each coverslip with purified DRGs. The medium used for 
the co-cultures was 50:50 DMEM/Neurobasal medium (Invitrogen) sup-
plemented with Sato and B27 (Invitrogen), NGF (100 g/ml), N-acetyl 
cysteine (5 µg/ml, Sigma-Aldrich), and d-biotin (10 g/ml). Co-cultures 
were maintained for 3 wk with medium and supplements changed every 
3–4 d. After 3 wk, the extent of myelination was quantified by determin-
ing the slope of the best-fit line defining the relationship between the per-
centage  of  oligodendrocytes  (defined  by  the  expression  of  MBP  as 
detected by immunohistochemistry) with myelin sheaths and the density 
of the underlying neurite network (Wang et al., 2007). The number and 
length of internodes was traced and measured using ImageJ software. 
The average number of primary processes (defined as those originated 
directly from the cell body) was quantified in MBP
+ oligodendrocytes at 
the initial stages of myelination, before internode formation, using Open-
Lab image analysis software (Improvision).
RT-PCR
Total RNA was extracted from mouse tissues using the RNeasy mini kit   
(QIAGEN), according to the manufacturer’s instructions, and subjected to one-
step RT-PCR (QIAGEN). The following primers were used for the extracellular 
1 integrin domain: B1ecF 5-tggacaatgtcacctggaaa-3, B1ecR 5-tgtgcccact-
gctgacttag-3; and for the IL2R extracellular domain: IL2RaF5-atcagtgcgtc-
cagggatac-3, IL2RaR 5-gacgaggcaggaagtctcac-3. Data were normalized 
to -actin levels (5-agccatgtacgtatccatcc-3 and 5-ctctcagctgtggtggtgaa-3). 
ImageJ software was used to quantify mRNA expression levels.
Western blot
Dissected tissues from dn1 and wild-type mice were homogenized in 1% 
SDS and subjected to SDS-PAGE using appropriate percentage of acryl-
amide minigels. They were then transferred onto 0.45-µm nitrocellulose 
membranes (HybondC; GE Healthcare) and blocked with 5% nonfat dry 
milk and 0.1% Tween 20 Tris-buffered saline (TBS) for 1 h at room tempera-
ture (RT). The primary antibody diluted in blocking solution was incubated 
for 2 h at RT or overnight (ON) at 4°C. The blots were then washed three 
times in TBS 0.1% Tween (TBS-T) and incubated for 1 h at RT with a horse-
radish peroxidase–labeled secondary antibody (GE Healthcare). After 
washing again in TBS-T the immunoreactive proteins were revealed by 
chemiluminescence (ECL; GE Healthcare) according to the manufacturer’s 
instructions. Digitalized images were obtained and bands quantified using 
ImageJ software.
Immunofluorescence and image acquisition
When staining for MBP on tissue sections, a post-fixation step prior stain-
ing was performed with 95% ethanol and 5% acetic acid for 30 min at 
20°C, followed by three rinses in PBS. Sections were then blocked for 
1 h in PBS containing 10% normal goat serum (NGS) and 0.1% Triton   
X-100 at RT, after which the primary antibody incubation was performed 
either ON at 4°C or for 2 h at RT. The following primary antibodies were 
used for immunofluorescence or Western blot: rat anti-MBP (AbD Sero-
tec),  mouse  anti-neurofilament  200  (Sigma-Aldrich),  rabbit  polyclonal 
anti-pFAK (Y397; Invitrogen), rabbit polyclonal anti-FAK (Invitrogen), and 
monoclonal mouse anti–human CD25/interleukin-2  receptor (Dako). 
After washing in PBS, the sections were incubated for 1 h with the sec-
ondary antibody (FITC or Alexa 588 and TRITC or Alexa 488 labeled) 
and Hoechst. After further washes in PBS, slides were mounted in fluoro-
mount (SouthernBiotech). All fluorescence images were acquired at RT 
with a fluorescence microscope (Axioplan; Carl Zeiss, Inc.), fitted with 
10x eyepiece magnification, 20x (0.5 NA) and 40x (0.75 NA) objec-
tives, and a digital camera (model C4742-95; Hamamatsu) using Open-
Lab image analysis software (Improvision).
myelination (Saito et al., 2003; Occhi et al., 2005; Colognato et al., 
2007). We propose, therefore, that the study of Lee et al. (2006) 
expressing 1C reveals a requirement for dystroglycan in later 
stages of myelin sheath formation in addition to the role of inte-
grins in the earlier stages of initiation. Our present and previous 
studies, by contrast, specifically target integrin signaling and 
would thus not reveal any later role of other laminin receptors.
The identification of the signals regulating the initiation of 
myelination may lead to the development of strategies to pro-
mote effective remyelination by oligodendrocytes within MS 
lesions arrested at the premyelinating stage and therefore un-
able to contribute to repair (Chang et al., 2002). Further studies 
examining the partners and ligands of the integrins expressed on 
oligodendrocytes represent promising new approaches toward 
understanding this goal.
Materials and methods
Cloning and dn1/dn3 ES cell generation
For the generation of the genetically modified embryonic stem (ES) cells ex-
pressing the dn1/dn3 integrin we used the hypoxanthine phosphoribo-
syl transferase (hprt) targeting system (Farhadi et al., 2003). This system 
relies on the use of an hprt-deficient ES cell line (Bronson et al., 1996; Farhadi 
et al., 2003) and on the cloning of the desired sequences onto a vector 
containing the deleted hprt sequences as well as the hprt homologous arms 
required for recombination.
The dominant-negative sequences were initially cloned into a Gate-
way entry vector containing the 9.5-Kb MBP promoter (pENTR1A9.5). The 
IL2R1 integrin sequence was available (Relvas et al., 2001) cloned as an 
XhoI fragment into XhoI of pLXIN vector (Clontech Laboratories, Inc.). We 
subsequently subcloned IL2R1 as an XhoIK-PstI + PstI-BamHI fragment into 
EcoRV-BamHI of pBluescript. The IL2R1 was then excised as an XhoI-ClaI 
fragment from pBluescript and cloned into pENTR1A9.5 linearized with SalI-
ClaI. The IL2R3 integrin sequence was also available cloned as an XhoI 
fragment into XhoI of pLXIN vector (Clontech Laboratories, Inc.). We subse-
quently subcloned IL2R3 as an XhoIK-HindIII + HindIII-BamHI fragment into 
EcoRV-BamHI of pBluescript. The IL2R3 was then excised as an XhoI-ClaI 
fragment from pBluescript and cloned into pENTR1A9.5 linearized with SalI-
ClaI. The clones were all confirmed by an extensive series of restriction di-
gests and the final clones in pENTR1A9.5 were also confirmed by automatic 
sequencing  using  the  primers  pE9.5bS  5-aaagcaggctttaaaggaacc-3, 
pE9.5aC 5-ggctgcaggaattcgatatca-3, and pE9.5mbpF 5-ttcccggggcatctc-
gggaaaag-3, pE9.5mbpR 5-aggccatcgccctctggagtggt-3. Transgenes 
cloned into pENTR1A9.5 vector were subsequently transferred to the hprt 
targeting destination vector, in vitro, using the Gateway technology (Invitro-
gen). Both transgenes were docked, in single copy and fixed orientation, in 
the 5 flanking sequence of the hprt locus on the X chromosome. BPES5 ES 
cells (Denarier et al., 2005), bearing the same hprt deletion as the original 
BK4 ES cells (Bronson et al., 1996), were electroporated with 40 µg of lin-
earized DNA and selected on HAT-supplemented medium as described pre-
viously (Farhadi et al., 2003). The HAT
+ ES cell clones were screened by PCR 
using the primers ESIL2Rb1II 5-cagagcttgtgcattgacattg-3 and pE9.5aC.
Generation of dominant-negative 1/3 integrin transgenic mice
The  genetically  altered  agouti  ES  cells  were  subsequently  injected  into 
C57BL/6-derived blastocysts that were then transplanted into the uteri of 
recipient females. Resulting chimeric males were bred with C57BL/6 fe-
males, and the F1 female agouti offspring were backcrossed with C57BL/6 
males. Genotyping was performed by PCR with a set of primers for the 
wild-type (PfHprt mus 5-gagggagaaaaatgcggagtg-3 and PrHprt mus   
5-ctccggaaagcagtgaggtaag-3) and a set of primers for the transgenic 
(ESIL2Rb1II and pE9.5aC) alleles. When further confirmation of sex deter-
mination was required, especially at young ages, PCR for the sex-determining 
region Y (SRY) gene was additionally performed. Mutant homozygous   
females and hemizygous males of the two dominant-negative lines were   
viable and showed no obvious behavioral abnormalities.
FAK knockout mice
The conditional inactivation of FAK in myelinating cells by crossing trans-
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Electron microscopy
Hemizygous and wild-type males were used as mutant and control mice, 
respectively. Anaesthetized mice were perfused intracardially with freshly 
prepared 4% glutaraldehyde containing 2 mmol/l CaCl2 in 0.1 M phos-
phate buffer (PB) at RT. Dissected tissues were incubated in the same solu-
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with saturated uranyl acetate in 50% ethanol and lead citrate and exam-
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